Recently, among multiple surgical techniques for the treatment of cholelithiasis and cholecystitis, laparoscopic cholecystectomy (LC) is a method of choice (
1,
2). Both neuraxial and general anesthesia are common anesthetic techniques in these patients. Various physiological changes may occur during anesthesia for laparoscopic surgery, which may lead to hemodynamic instability, increase in intra-abdominal pressure caused by pneumoperitoneum (CO
2 insufflation), and patient position (
3). Following the painful irritations that occur after the induction of anesthesia and during surgery, the patient’s stress responses are triggered. Hence, choosing a method that minimizes the hormonal fluctuations caused by stress responses will be desirable (
4). Today, one of the serious concerns of researchers and physicians is to find effective medications to control the increase of inflammatory and stress responses. Epinephrine is a neurotransmitter of the endogenous catecholamines group, which causes an increase in heart rate, vasoconstriction, and dilatation of airways (
5).
Propofol generates the most pronounced decrease in systemic blood pressure compared with other anesthetics, which, in addition to rapid anesthetic effects and lower side effects, has a faster anesthesia return than other intravenous anesthetics (
6-
8); it is also known as the best anesthetic drug for continuous infusion due to its rapid metabolism and the lack of cumulative effects. After the induction of anesthesia, propofol may result in a decrease in blood pressure and bradycardia due to less inhibition of the parasympathetic nervous system compared to sympathetic one.
The use of preoperative α2 receptor agonists improves hemodynamic stability due to its numerous beneficial effects, including analgesic effects, inhibition of sympathetic outputs, anti-anxiety properties, and reduction of norepinephrine levels (
9). They protect myocardial muscle because of positive effects on myocardial oxygen supply and cardiac oxygen demand (
10-
13). Stress response involves various hormones, such as release of epinephrine, cortisol, some cytokines like interleukin, TNF, and growth factors, and complement system activation. This stress response to surgery can be reduced by activating an alpha-dual adrenergic receptor (
14,
15). Dexmedetomidine is a highly selective α2 receptor agonist with 1600-fold affinity to α1 receptor (
16). The use of dexmedetomidine before anesthesia has a positive effect on hemodynamic stability, which has been associated with reduced postoperative mortality and reduction of unpleasant postoperative complications (
17-
20). The results of laboratory and clinical studies showed that dexmedetomidine reduces inflammatory responses (
21,
22), and animal studies also showed inhibition of pro-inflammatory cytokines (
23). In addition, the results of in vitro studies on whole human blood samples reported suppression of lipopolysaccharides, which produce pro-inflammatory mediators including TNF-α, interleukin-6, and IL-8 (
24,
25). Besides vasodilatory effects, alpha-2 agonists have sympathetic suppressive, sedative, and hypnotic effects (
26). Alpha-2 agonists, such as clonidine, have a blood pressure lowering effect, and therefore reduce surgical bleeding (
16,
27); in addition, dexmedetomidine facilitates analgesia and anesthesia in humans and reduces the severity of postoperative pain and nausea (
28-
30). This drug is approved for use for up to 24 hours at a maximum dose of 0.7 micrograms per kilogram of body weight per hour (
31). Several studies showed that dexmedetomidine is relatively safe even after long-term administration in high doses, with few side effects (
32). Intravenous dexmedetomidine reduces the need to use high dose of propofol administration to achieve and maintain desirable bispectral index score (BIS) with low side effect (
33).